Senior Director, Corporate Affairs, Communication and Policy Advocacy, Midsized Markets
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Senior Director, Corporate Affairs will lead the development and execution of oncology-focused Corporate Affairs strategies in the Midsized Markets that support the company’s mission of revolutionizing treatment for patients with RAS-addicted cancers. These Corporate Affairs strategies bring together media relations, corporate public affairs, product communications, corporate reputation management and internal communications.
This is an intentionally broad remit, spanning a wide range
